Loading stock data...

Tiaan Consumer Ltd.

BSE: TIAANC

BSE
6.60 0.16 (2.48%)

Prev Close

6.44

Open Price

6.59

Volume

22,462

Today Low / High

6.12 / 6.6

52 WK Low / High

4.37 / 9.24

Range

6 - 7

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 6.6, reflecting a change of 0.16 (2.48447%). The expected target range on the BSE is 6 - 7. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

21 Nov 6.59 0.15%
19 Nov 6.37 0.31%
18 Nov 6.04 0.83%
17 Nov 6.35 0.00%
14 Nov 6.80 -1.76%
13 Nov 6.69 -1.94%
12 Nov 6.47 -1.24%
11 Nov 6.05 1.98%
10 Nov 5.85 0.85%
07 Nov 5.78 5.02%
06 Nov 6.15 -5.04%
04 Nov 6.65 -7.67%
03 Nov 6.36 0.00%
27 Oct 6.69 0.00%

Tiaan Consumer Ltd. Graph

Tiaan Consumer Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Tiaan Consumer Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 6.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 6.60 6.67 6.00 - 7.33
6.73 5.39 - 8.08
6.80 4.76 - 8.84
Bearish Scenario 6.60 6.53 5.88 - 7.19
6.47 5.17 - 7.76
6.40 4.48 - 8.32

Overview of Tiaan Consumer Ltd.

ISIN

INE864T01011

Industry

Medical - Pharmaceuticals

Vol.Avg

15,893

Market Cap

67,775,499

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

5.50

DCF

-1

Financial Ratios Every Investor Needs

Stock Dividend of TIAANC

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2020-03-19 March 19, 20 0.03018869 0.06 2020-03-20 2020-06-18

Stock Rating Details for TIAANC

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.10 Cr 0.00 Cr 0.09 Cr 0.9506 0.00 Cr 0.02 Cr -0.18 Cr 0.03 Cr 0.00 0.03 Cr 0.3628
2024-03-31 0.29 Cr 0.29 Cr 0.00 Cr 0.0010 0.00 Cr 0.03 Cr -0.15 Cr -0.32 Cr -0.03 -0.15 Cr -1.0991
2023-03-31 0.00 Cr 1.78 Cr -1.78 Cr 0.0000 0.00 Cr 0.01 Cr -1.79 Cr -2.38 Cr -2.32 -1.91 Cr 0.0000
2022-03-31 0.12 Cr 0.09 Cr 0.03 Cr 0.2615 0.00 Cr 0.01 Cr -0.08 Cr -0.32 Cr -0.31 -0.12 Cr -2.7932
2021-03-31 4.09 Cr 2.03 Cr 2.06 Cr 0.5040 0.00 Cr 0.06 Cr 1.69 Cr 0.94 Cr 0.91 1.46 Cr 0.2294

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.02 Cr 2,507.00 Cr 2,500.02 Cr 6.9799 Cr 2,500.00 Cr 2,499.98 Cr 3.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0241 Cr
2024-03-31 0.00 Cr 15.42 Cr 8.48 Cr 6.9454 Cr 5.19 Cr 5.19 Cr 3.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 3.2840 Cr
2023-03-31 0.13 Cr 9.51 Cr 1.50 Cr 8.0145 Cr 1.48 Cr 1.34 Cr 3.71 Cr 0.75 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.4979 Cr
2022-03-31 0.01 Cr 10.51 Cr 0.12 Cr 10.3954 Cr 0.03 Cr 0.03 Cr 3.09 Cr 1.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.1191 Cr
2021-03-31 0.03 Cr 11.17 Cr 0.45 Cr 10.7170 Cr 0.07 Cr 0.04 Cr 3.00 Cr 1.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.4535 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.2269 Cr -2,492.3281 Cr 2,494.8074 Cr -3.2269 Cr -0.7476 Cr 0.0610 Cr 0.0000 Cr 0.0345 Cr 2,494.8074 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 2.6630 Cr -5.7100 Cr 3.7126 Cr 2.6630 Cr 0.6656 Cr 0.8011 Cr 0.0000 Cr -0.3191 Cr 3.7126 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -1.3143 Cr 0.0000 Cr 1.4448 Cr -1.3037 Cr 0.1305 Cr 0.1355 Cr 0.0000 Cr -2.3810 Cr 1.4800 Cr 0.0000 Cr -0.6247 Cr
2022-03-31 -0.0253 Cr 0.0000 Cr 0.0000 Cr -0.0253 Cr -0.0253 Cr 0.0050 Cr 0.0000 Cr -0.3215 Cr 0.0000 Cr 0.0000 Cr -0.0850 Cr
2021-03-31 0.4556 Cr -0.4522 Cr 0.0000 Cr 0.4556 Cr 0.0034 Cr 0.0303 Cr 0.0000 Cr 0.9381 Cr 0.0000 Cr 0.0000 Cr 0.2423 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 0.05 Cr 0.00 Cr 0.00 Cr -0.0470 -0.01 Cr 0.05 Cr 0.05 0.05 Cr 0.8854
2025-03-31 0.03 Cr 0.00 Cr 0.02 Cr 0.9078 0.02 Cr 0.00 Cr -0.01 0.00 Cr -0.1913
2024-12-31 0.07 Cr 0.00 Cr 0.07 Cr 1.0000 -0.16 Cr 0.05 Cr 0.05 0.05 Cr 0.7875
2024-09-30 0.01 Cr 0.00 Cr 0.01 Cr 1.0000 0.01 Cr -0.01 Cr -0.02 -0.02 Cr -2.0354
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 1.0000 0.00 Cr -0.01 Cr -0.01 0.00 Cr -2.0231

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 1,025.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -6.98 Cr
2025-03-31 0.02 Cr 1,022.00 Cr 0.06 Cr 1,481.52 Cr 3.42 Cr 1,485.00 Cr 0.00 Cr 2,507.00 Cr 2,500.02 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -6.94 Cr
2024-09-30 0.00 Cr 1.46 Cr 1.46 Cr 5.19 Cr 3.42 Cr 10.08 Cr 0.00 Cr 16.08 Cr 9.14 Cr
2024-06-30 0.00 Cr 0.00 Cr 10.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -6.95 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.01 Cr 1,024.53 Cr -1,024.33 Cr -0.18 Cr 0.02 Cr 0.06 Cr 0.04 Cr 0.00 Cr 1,024.53 Cr
2024-12-31 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.01 Cr 0.12 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.12 Cr
2024-06-30 -0.01 Cr 0.12 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.12 Cr

Splits History

Date Label Split Ratio
2021-07-20 July 20, 21 1589:1000
2020-07-02 July 02, 20 5:4

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹767.40 ₹91,909,729,910.00 ₹138,681.00

Key Executives

Managing Director
Mr. Parmanand Chaubey

Gender: male

Year Born: 1976

Company Secretary & Compliance officer
Ms. Apra Sharma

Gender: female

Year Born: 1986

Chief Financial Officer
Mr. Ajay Khanna

Gender: male

Year Born:

FAQs about Tiaan Consumer Ltd.

Who is the CEO of the company?

The CEO is Parmanand Chaubey.

What is the current market price of the stock?

The current price is ₹6.60.

What is the 52-week price range?

The range is ₹4.37-9.24.

What is the market capitalization of the company?

The market capitalization is ₹6.78 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 83.63.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Tiaan Consumer Ltd. (ISIN: INE864T01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹6.78 crores and an average daily volume of 15,893 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.